GlobeNewswire Inc.··Abli TherapeuticsABLi Therapeutics Bolsters Board with Roche Neurology Veteran Ahead of Phase 3 Push
ABLi Therapeutics appoints Dr. Rachelle Doody, Roche neurology veteran, to board as company advances risvodetinib into Phase 3 trials for Parkinson's and related diseases.
RHHBYPhase 3 clinical trialdrug development